The scientific basis for regarding vitamin A and its analogues as anti-carcinogenic agents.
D000818:Animals; D000970:Antineoplastic Agents; D002085:Butylhydroxybutylnitrosamine; D002278:Carcinoma in Situ / Q000188:drug therapy; D002291:Carcinoma, Papillary / Q000188:drug therapy; D002338:Carotenoids / Q000627:therapeutic use; D002454:Cell Differentiation / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D004848:Epithelium / Q000502:physiology; D017313:Fenretinide; D006801:Humans; D015474:Isotretinoin; D009369:Neoplasms / Q000517:prevention & control; D009374:Neoplasms, Experimental / Q000139:chemically induced / Q000188:drug therapy; D014212:Tretinoin / Q000031:analogs & derivatives / Q000627:therapeutic use; D001749:Urinary Bladder Neoplasms / Q000139:chemically induced / Q000188:drug therapy; D014801:Vitamin A / Q000031:analogs & derivatives / Q000627:therapeutic use* / Q000633:toxicity; D019207:beta Carotene
D000970:Antineoplastic Agents; D019207:beta Carotene; D014801:Vitamin A; D017313:Fenretinide; C009675:vitamin A acid ethylamide; D002338:Carotenoids; D002085:Butylhydroxybutylnitrosamine; D014212:Tretinoin; D015474:Isotretinoin